218 related articles for article (PubMed ID: 36622276)
1. WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth.
Wang K; Ma F; Arai S; Wang Y; Varkaris A; Poluben L; Voznesensky O; Xie F; Zhang X; Yuan X; Balk SP
Cancer Res; 2023 Apr; 83(7):1016-1030. PubMed ID: 36622276
[TBL] [Abstract][Full Text] [Related]
2. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
[TBL] [Abstract][Full Text] [Related]
3. Noncanonical Wnt5a Signaling Suppresses Hippo/TAZ-Mediated Osteogenesis Partly Through the Canonical Wnt Pathway in SCAPs.
Fu Y; Ma D; Fan F; Sun T; Han R; Yang Y; Zhang J
Drug Des Devel Ther; 2022; 16():469-483. PubMed ID: 35237028
[TBL] [Abstract][Full Text] [Related]
4. Wnt5a suppresses osteoblastic differentiation of human periodontal ligament stem cell-like cells via Ror2/JNK signaling.
Hasegawa D; Wada N; Yoshida S; Mitarai H; Arima M; Tomokiyo A; Hamano S; Sugii H; Maeda H
J Cell Physiol; 2018 Feb; 233(2):1752-1762. PubMed ID: 28681925
[TBL] [Abstract][Full Text] [Related]
5. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.
Maeda K; Kobayashi Y; Udagawa N; Uehara S; Ishihara A; Mizoguchi T; Kikuchi Y; Takada I; Kato S; Kani S; Nishita M; Marumo K; Martin TJ; Minami Y; Takahashi N
Nat Med; 2012 Feb; 18(3):405-12. PubMed ID: 22344299
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of WNT5A/ROR2 Signaling Characterizes the Progression of Barrett-Associated Esophageal Adenocarcinoma.
Lyros O; Nie L; Moore T; Medda R; Otterson M; Behmaram B; Mackinnon A; Gockel I; Shaker R; Rafiee P
Mol Cancer Res; 2016 Jul; 14(7):647-59. PubMed ID: 27084312
[TBL] [Abstract][Full Text] [Related]
7. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.
O'Connell MP; Fiori JL; Xu M; Carter AD; Frank BP; Camilli TC; French AD; Dissanayake SK; Indig FE; Bernier M; Taub DD; Hewitt SM; Weeraratna AT
Oncogene; 2010 Jan; 29(1):34-44. PubMed ID: 19802008
[TBL] [Abstract][Full Text] [Related]
8. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of Ror2 suppresses TNF‑α‑induced inflammation and apoptosis in vascular endothelial cells.
Yang X; Zhao S; Yuan H; Shi R; Gu W; Gu Z; Lu X; Zhao H
Mol Med Rep; 2020 Oct; 22(4):2981-2989. PubMed ID: 32945438
[TBL] [Abstract][Full Text] [Related]
10. circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling.
Wan J; Liu Y; Long F; Tian J; Zhang C
Cancer Sci; 2021 May; 112(5):1707-1722. PubMed ID: 33369809
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of Ror2 and Wnt5a expression in medulloblastoma.
Lee SE; Lim SD; Kang SY; Suh SB; Suh YL
Brain Pathol; 2013 Jul; 23(4):445-53. PubMed ID: 23278988
[TBL] [Abstract][Full Text] [Related]
12. Wnt5A and TGFβ1 Converges through YAP1 Activity and Integrin Alpha v Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation.
Dehghani-Ghobadi Z; Sheikh Hasani S; Arefian E; Hossein G
Cells; 2022 Jan; 11(2):. PubMed ID: 35053353
[TBL] [Abstract][Full Text] [Related]
13. Ror2/Frizzled complex mediates Wnt5a-induced AP-1 activation by regulating Dishevelled polymerization.
Nishita M; Itsukushima S; Nomachi A; Endo M; Wang Z; Inaba D; Qiao S; Takada S; Kikuchi A; Minami Y
Mol Cell Biol; 2010 Jul; 30(14):3610-9. PubMed ID: 20457807
[TBL] [Abstract][Full Text] [Related]
14. Wnt5a and Ror2 expression associate with the disease progress of primary thyroid lymphoma.
Wang L; Yang D; Wang YH; Li X; Gao HM; Lv JY; Wang L; Xin SJ
Tumour Biol; 2016 May; 37(5):6085-90. PubMed ID: 26608372
[TBL] [Abstract][Full Text] [Related]
15. Spinal Wnt5a Plays a Key Role in Spinal Dendritic Spine Remodeling in Neuropathic and Inflammatory Pain Models and in the Proalgesic Effects of Peripheral Wnt3a.
Simonetti M; Kuner R
J Neurosci; 2020 Aug; 40(35):6664-6677. PubMed ID: 32616667
[TBL] [Abstract][Full Text] [Related]
16. Dissection of Wnt5a-Ror2 signaling leading to matrix metalloproteinase (MMP-13) expression.
Yamagata K; Li X; Ikegaki S; Oneyama C; Okada M; Nishita M; Minami Y
J Biol Chem; 2012 Jan; 287(2):1588-99. PubMed ID: 22128168
[TBL] [Abstract][Full Text] [Related]
17. Wnt5A regulates the expression of ROR2 tyrosine kinase receptor in ovarian cancer cells.
Hossein G; Arabzadeh S; Salehi-Dulabi Z; Dehghani-Ghobadi Z; Heidarian Y; Talebi-Juybari M
Biochem Cell Biol; 2017 Dec; 95(6):609-615. PubMed ID: 28538104
[TBL] [Abstract][Full Text] [Related]
18. The role of WNT5A and Ror2 in peritoneal membrane injury.
Padwal M; Liu L; Margetts PJ
J Cell Mol Med; 2020 Mar; 24(6):3481-3491. PubMed ID: 32052562
[TBL] [Abstract][Full Text] [Related]
19. Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2.
Yamamoto H; Yoo SK; Nishita M; Kikuchi A; Minami Y
Genes Cells; 2007 Nov; 12(11):1215-23. PubMed ID: 17986005
[TBL] [Abstract][Full Text] [Related]
20. WNT5A-ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3.
Arabzadeh S; Hossein G; Salehi-Dulabi Z; Zarnani AH
Cell Mol Biol Lett; 2016; 21():9. PubMed ID: 28536612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
